Tumour CD45+/CD11b− cells from mice treated with TNFα‐CSG expressed twofold to 20‐fold higher levels of mRNAs for multiple proteases than cells from the CSG‐treated tumours. This evidence concerns the gene ITGAM and neoplasm.